Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Kidney Neoplasms × pazopanib × Clear all

Phase

Phase 2 2 Phase 1 2 Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 4 Sarcoma 2 Refractory Solid Tumors 2 Neoplasms 2 Kidney Neoplasms 1

Interventions

Sunitinib 5 Radiosurgery 5 Blood Specimen Collection 4 Surgical Procedures, Operative 3 fludarabine phosphate 2 Robotic Surgical Procedures 2 Peripheral Blood Stem Cell Transplantation 2 Magnetic Resonance Spectroscopy 2 Exercise 2 Cyclophosphamide 2 Cryosurgery 2 temsirolimus 1 salicylhydroxamic acid 1 perflutren 1 pazopanib 1 erythromycin propionate-N-acetylcysteinate 1 Watchful Waiting 1 Warm Ischemia 1 Urination 1 Ultrasonography 1 Tumor Burden 1 Traumeel S 1 Therapeutics 1 Tacrolimus 1 Surveys and Questionnaires 1 Standard of Care 1 Spermine Synthase 1 Sorafenib 1 Social Determinants of Health 1 Ropivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03571438 2020-01-18

COMBOREIN

University Hospital, Grenoble

Phase NA Unknown

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡